Anti-β2-glycoprotein I antibody in young adult patients with either ischemic stroke or livedo reticularis;Accident vasculaire cerebral du sujet jeune et/ou livedo: Y a-t-il un interet a rechercher les anticorps anti-β2-glycoproteine I?

Revue de Medecine Interne

Volumn 19, Issue 10, 1998, Pages 709-712

  Granel, F ^a   De Maistre, E ^b   Challier, B ^c   Weber, M ^a,d   Schmutz, J L ^a  

^a Service de Dermatologie   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c SIMES   (France)

^d Hopital Saint Julien Nancy   (France)

Author keywords

Anti 2 glycoprotein I antibodies; Ischemic stroke; Livedo reticularis; Sneddon's syndrome

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; APOLIPOPROTEIN; GLYCOPROTEIN; MEMBRANE PROTEIN;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; LABORATORY TEST; LIVEDO RETICULARIS; MALE; ONSET AGE; SNEDDON SYNDROME; STROKE; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MIDDLE AGED; RISK FACTOR; SKIN BLOOD VESSEL DISORDER;

ADULT; AGED; ANTIBODIES, ANTICARDIOLIPIN; APOLIPOPROTEINS; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CEREBROVASCULAR DISORDERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RISK FACTORS; SKIN DISEASES, VASCULAR;

EID: 0032435017     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0248-8663(98)80705-4     Document Type: Article

References (17)

1. Aubry F, Crickx B, Nicaise P, Labarre C, Viard JP, Belaïch S. Les anticorps anti-bêta2-glycoproteine I dans le livedo reticularis idiopathique. Ann Dermatol Vénéréol. 122:1995;667-670.
2. Francès C, Piette JC, Viard JP, Bérard M, Tourbah H, Cosnes A. Anticorps anti-phospholipides et anti-bêta2glycoprotéine I dans le syndrome de Sneddon. À propos de 20 cas. In: Journées parisiennes de dermatologie Ann Dermatol Vénéréol. 18:1993;C22.
3. Zuber M, Toulon P, Mas JL. Resistance to activated protein C in cerebral thromboembolism: a case control study. Cerebrovasc Dis. 5:1995;189.
4. Gallo P, Sivieri S, Ferrarini AM, Giometto B, Ruffatti A, Ritter E, et al. Cerebrovascular and neurological disorders associated with antiphospholipides antibodies in CSF and serum. J Neurol Sci. 122:1994;97-100.
5. Chancellor AM, Cull RE, Kilpatrick DC, Warlow CP. Neurological disease associated with anticardiolipin antibodies in patients without systemic lupus erythematosus. J Neurol. 238:1991;401-407.
6. Galli M, Bevers EM, Barbui T. Interactions between antiphospholipid antibodies and blood cells. Nouv Rev Fr Hématol. 37:1995;43-48.
7. Dewitt LD, Caplan LR. Antiphospholipid antibodies and stroke. Am J Neuroradiol. 12:1991;454-456.
8. Eng AM. Cutaneous expressions of antiphospholipid syndromes. Semin Thromb Hemostasis. 20:1994;71-78.
9. Coull BM, Levine SR, Brey RL. The role of antiphospholipid antibodies in stroke. Neurol Clin. 10:1992;125-142.
10. Piette JC, Wechsler B, Blétry O, Frances C, Cacoub P, Le Thi Huonk Du, Laraki R, et al. Antiphospholipid syndrome. Ann Méd Interne. 143:1992;25-39.
11. Feldmann E, Levine SR. Cerebrovascular disease with antiphospholipid antibodies: immune mechanism, significance, and therapeutic options. Ann Neurol. 37:1995;114-130. (suppl).
12. Carreras L, Maclouf J, Tobelem G. Physiopathologie du syndrome des antiphospholipides. Sang Thromb Vaiss. 4:1992;183-189.
13. Sanmarco M, Soler C. Heterogencity of anti β2 glycoprotein I antibodies. Nouv Rev Fr Hématol. 37:1995;57-60.
14. Feldman L, Saveuse H, Dechy H, Houbouyan L, Lesur G, Piette JC, et al. Accidents vasculaires à répétition, anticorps antiphospholipides et lupus érythémateux. Ann Méd Interne. 142:1991;543-559.
15. Scrobohaci ML, Freyssinet JM. Anticorps antiphospholipides, syndrome des antiphospholipides. Cause ou conséquence de la thrombose. Pathol Biol. 39:1991;709-715.
16. Devilat M, Toso M, Morales M. Childhood stroke associated with protein C or S deficiency and primary antiphospholipid syndrome. Pediatr Neurol. 9:1993;167-170.
17. Abuaf N, Rajoely B, Barthet C, Deschamps A, Bouchet MC, Rouquette AM, et al. Prevalence of anti β2 glycoprotein I and of antiprothrombin antibodies in 2 174 patients in 107 healthy controls. Nouv Rev Fr Hématol. 37:1995;53-56.